Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flaminal Forte versus Flammazine for partial-thickness burns
NL-OMON40281Active, not recruiting
- Sponsor
- Rode Kruis Ziekenhuis
- Start
- Feb 2014
- Modality
- Small Molecules, Therapeutic Enzymes → Recombinant Proteins and Enzymes, Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Randomised, open-label trial in burn injury comparing Flaminal Forte with Flammazine (2 arms). Primary endpoint: Time to complete re-epithelialization. Started Feb 2014; status: active, not recruiting.
02
Drugs
Flaminalsilver sulfadiazine
03
Conditions
burn injury
Beyond the preview
Go deeper on NL-OMON40281.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON40281.